帕金森病冻结步态的多模态影像学研究进展

doi:10.3969/j.issn.1671-7171.2025.10.003

摘要
图/表
参考文献
相关文章 (15)

[1] RAHIMPOUR S, GAZTANAGA W, YADAV A P, et al. Freezing of Gait in Parkinson's Disease: Invasive and Noninvasive Neuromodulation[J].Neuromodulation,2021, 24(5): 829-842.
[2] KOSTIC V S, AGOSTA F, PIEVANI M, et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease[J].Neurology,2012, 78(6): 409-416.
[3] WANG X, CHEN H, MA X, et al. Atrophy of ventral diencephalon is associated with freezing of gait in Parkinson's disease: analysis of two cohorts[J].NPJ Parkinsons Dis,2025, 11(1): 44.
[4] D'CRUZ N, VERVOORT G, CHALAVI S, et al. Thalamic morphology predicts the onset of freezing of gait in Parkinson's disease[J].NPJ Parkinsons Dis,2021, 7(1): 20.
[5] PASQUINI J, BROOKS D J, PAVESE N. The Cholinergic Brain in Parkinson's disease[J].Mov Disord Clin Pract,2021, 8(7): 1012-1026.
[6] LIN F B, ZOU X Y, SU J Q, et al. Cortical thickness and white matter microstructure predict freezing of gait development in Parkinson's disease[J].NPJ Parkinsons Dis,2024, 10(1): 16.
[7] LIN C, RIDDER M C, SAH P. The PPN and motor control: Preclinical studies to deep brain stimulation for Parkinson's disease[J].Front Neural Circuits,2023, 17: 1095441.
[8] YOUN J, LEE J M, KWON H, et al. Alterations of mean diffusivity of pedunculopontine nucleus pathway in Parkinson's disease patients with freezing of gait[J].Parkinsonism Relat Disord,2015, 21(1): 12-17.
[9] CANU E, AGOSTA F, SARASSO E, et al. Brain structural and functional connectivity in Parkinson's disease with freezing of gait[J].Hum Brain Mapp,2015, 36(12): 5064-5078.
[10] REN Q Q, ZHAO S, YU R, et al. Thalamic-limbic circuit dysfunction and white matter topological alteration in Parkinson's disease are correlated with gait disturbance[J].Front Aging Neurosci,2024, 16: 1426754.
[11] TESSITORE A, AMBONI M, ESPOSITO F, et al. Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait[J].Parkinsonism Relat Disord,2012, 18(6): 781-787.
[12] FLING B W, COHEN R G, MANCINI M, et al. Functional reorganization of the locomotor network in Parkinson patients with freezing of gait[J].PLoS One,2014, 9(6): e100291.
[13] GILAT M, EHGOETZ MARTENS K A, MIRANDA-DOMíNGUEZ O, et al. Dysfunctional limbic circuitry underlying freezing of gait in Parkinson's disease[J].Neuroscience,2018, 374(1): 119-132.
[14] SNIJDERS A H, LEUNISSEN I, BAKKER M, et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait[J].Brain,2011, 134(Pt 1): 59-72.
[15] BAO Y Q, YA Y, LIU J, et al. Regional homogeneity and functional connectivity of freezing of gait conversion in Parkinson's disease[J].Front Aging Neurosci,2023, 15: 1179752.
[16] DJALDETTI R, RIGBI A, GREENBAUM L, et al. Can early dopamine transporter imaging serve as a predictor of Parkinson's disease progression and late motor complications?[J].J Neurol Sci,2018, 390(2): 255-260.
[17] CALABRESI P, PICCONI B, TOZZI A, et al. Direct and indirect pathways of basal ganglia: a critical reappraisal[J].Nat Neurosci,2014, 17(8): 1022-1030.
[18] GAN C T, CAO X Y, WANG L, et al. Cholinergic basal forebrain atrophy in Parkinson's disease with freezing of gait[J].Ann Clin Transl Neurol,2023, 10(5): 814-824.
[19] BOHNEN N I, KANEL P, ZHOU Z, et al. Cholinergic system changes of falls and freezing of gait in Parkinson's disease[J].Ann Neurol,2019, 85(4): 538-549.
[20] ANANTH M R, RAJEBHOSALE P, KIM R, et al. Basal forebrain cholinergic signalling: development, connectivity and roles in cognition[J].Nat Rev Neurosci,2023, 24(4): 233-251.
[21] ECK S R, XU S J, TELENSON A, et al. Stress regulation of sustained attention and the cholinergic attention system[J].Biol Psychiatry,2020, 88(7): 566-575.
[22] SARTER M, ALBIN R L, KUCINSKI A,et al. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function[J].Exp Neurol,2014, 257: 120-129.
[23] MCKAY J L, NYE J, GOLDSTEIN F C, et al. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease[J].Neurobiol Dis,2023, 179: 106048.
[24] DEVOS D, DEFEBVRE L, BORDET R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease[J].Fundam Clin Pharmacol,2010, 24(4): 407-421.
[25] IMAMURA K, OKAYASU N, NAGATSU T. Cerebral blood flow and freezing of gait in Parkinson's disease[J].Acta Neurol Scand,2012, 126(3): 210-218.
[26] BALLANGER B, LOZANO A M, MORO E, et al. Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O]H₂O PET study[J].Hum Brain Mapp,2009, 30(12): 3901-3909.